Augmedix to Report 2021 Second Quarter Financial Results on August 10, 2021
SAN FRANCISCO, July 27, 2021 (GLOBE NEWSWIRE) -- Augmedix, Inc. (OTCQX: AUGX), a leading provider of virtual medical documentation and live clinical support, today announced it will report financial results for the second quarter 2021 on Tuesday, August 10, 2021 after market close. Company management will host a corresponding conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Conference Call & Webcast Details
The conference call can be accessed by dialing +1 (877) 407-3982 for U.S. participants or +1 (201) 493-6780 for international participants and referencing conference ID #13721620. Interested parties may access a live and archived webcast of the event on the “Investor Relations” section of the Company’s website at: https://ir.augmedix.com/.
About Augmedix
Augmedix, Inc. (OTCQX: AUGX) humanizes the clinician-patient experience by enabling clinicians to focus on what matters most: delivering high-quality patient care. Augmedix converts natural clinician-patient conversation into medical documentation and provides real-time administrative support, including referrals, orders, and reminders. The Augmedix service platform is powered by intelligent automation technologies that are overseen by virtual healthcare data specialists, who are highly trained medical scribes operating in HIPAA-secure locations. The service, which supports over 35 specialties, timely delivers accurate and comprehensive medical documentation to several of the largest healthcare systems in the U.S. and to hundreds of independent clinicians, supporting medical offices, clinics, hospitals, emergency departments and telemedicine practices nationwide. Augmedix can save clinicians 2–3 hours per day, improve clinician productivity by as much as 20%, and increase clinicians' satisfaction with work-life balance over 40%. To learn more about Augmedix, visit augmedix.com.
Investors:
Caroline Paul
Gilmartin Group
investors@augmedix.com
Media:
Kaila Grafeman
Augmedix
pr@augmedix.com
Released July 27, 2021